Sestak I, Regan M, Dodson A, et al. Integration of clinical variables for the prediction of late distant recurrence in patients with oestrogen receptor positive breast cancer treated with 5 years of endocrine therapy. SABCS 2017, GS6-01.
Fusie Lymph&Co, 2,6 miljoen euro extra voor wetenschappelijk onderzoek
feb 2018 | Lymfoom